Literature DB >> 29808004

Modeling cytokine release syndrome.

Cliona Rooney1, Tim Sauer2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29808004     DOI： 10.1038/s41591-018-0068-9

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

1.  First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

Authors:  Sarah Cooley; Fiona He; Veronika Bachanova; Gregory M Vercellotti; Todd E DeFor; Julie M Curtsinger; Paul Robertson; Bartosz Grzywacz; Kevin C Conlon; Thomas A Waldmann; David H McKenna; Bruce R Blazar; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Blood Adv       Date:  2019-07-09

Review 2.  The amount of cytokine-release defines different shades of Sars-Cov2 infection.

Authors:  S Bindoli; M Felicetti; P Sfriso; A Doria
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-28

Review 3.  Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy.

Authors:  Jie Li; Yiqian Luo; Baoqin Li; Yuanliang Xia; Hengyi Wang; Changfeng Fu
Journal:  Front Bioeng Biotechnol       Date:  2020-11-30

4.  Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia.

Authors:  A Manfredi; F Luppi; G Cassone; C Vacchi; C Salvarani; M Sebastiani
Journal:  Expert Rev Clin Immunol       Date:  2020-10-03       Impact factor: 4.473

5.  Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling.

Authors:  Noha M Elemam; Sarah Hammoudeh; Laila Salameh; Bassam Mahboub; Habiba Alsafar; Iman M Talaat; Peter Habib; Mehmood Siddiqui; Khalid Omar Hassan; Omar Yousef Al-Assaf; Jalal Taneera; Nabil Sulaiman; Rifat Hamoudi; Azzam A Maghazachi; Qutayba Hamid; Maha Saber-Ayad
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.